関連する実験動画
アクロメガリックのロザリオ.
H K Ibbertson1, P J Manning, I M Holdaway
1Department of Medicine, University of Auckland School of Medicine, New Zealand.
Lancet (London, England)
|January 19, 1991
まとめ
拡大したコストコンドラ結路は,アクロメガリー患者の一般的な兆候です. この発見は,成長ホルモンの過剰の有用な生物学的マーカーとして役立つ可能性があります.
科学分野:
- 内分泌学 エンドックリノロジー
- クリニカル・メディシン 臨床医学
背景:
- 過剰な成長ホルモンによって引き起こされる状態であるアクロメガリーは,様々な臨床的表れを示します.
- コストコンドラ結節は,内分泌系疾患の変化に敏感な解剖学的部位である.
関連する概念動画
こちらも読む
関連記事
共著者、ジャーナル、引用グラフによってこの研究に関連する記事。
並び替え
Same author
Muscle water properties in raw intact broiler breast fillets with the woody breast condition.
Poultry science·2020
Same author
Body composition of New Zealand-born term babies differs by ethnicity, gestational age and sex.
Early human development·2019
Same author
WITHDRAWN: GLP-1 Has an Anti-Inflammatory Effect on Adipose Tissue Expression of Cytokines, Chemokines, and Receptors in Obese Women.
The Journal of clinical endocrinology and metabolism·2019
Same author
Inaccurate retraction notice for meta-analysis by Iwamoto et al.
Acta neurologica Scandinavica·2018
Same author
Exudate Protein Composition and Meat Tenderness of Broiler Breast Fillets.
Poultry science·2015
Same author
Long-term effectiveness of a community-based model of care in Māori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) study.
Internal medicine journal·2015
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026